Long-term effect of persistent smoking on the prognosis of Chinese male patients after percutaneous coronary intervention with drug-eluting stent implantation

Journal of Cardiology

Volumn 62, Issue 5, 2013, Pages 283-288

  Liu, Jun ^a   Zhu, Zhong yu ^a   Gao, Chuan yu ^a,b   Wang, Xian pei ^a   Zhang, You ^a,b   Jin, Wei dong ^c   Qi, Da tun ^a   Li, Mu wei ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Henan Institute of Cardiovascular Epidemiology   (China)

^c XINXIANG CENTRAL HOSPITAL   (China)

Author keywords

Coronary heart disease; Drug eluting stent; Percutaneous coronary intervention; Prognosis; Smoking status

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE; DRUG ELUTING STENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PROGNOSIS; SMOKING; SMOKING CESSATION; WEIGHT GAIN;

CORONARY HEART DISEASE; DRUG-ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SMOKING STATUS;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CEREBROVASCULAR DISORDERS; CHINA; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 84887147434     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.05.010     Document Type: Article

References (24)

1. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004, 43:173l-177l.
2. Erhardt L. Cigarette smoking: an undertreated risk factor for cardiovascular disease. Atherosclerosis 2009, 205:23-32.
3. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008, 6:883-895.
4. Ockene J.K., Hosmer D., Rippe J., Williams J., Goldberg R.J., DeCosimo D., Maher P.M., Dalen J.E. Factors affecting cigarette smoking status in patients with ischemic heart disease. J Chronic Dis 1985, 48:985-994.
5. Bakhru A., Erlinger T.P. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005, 2:e160.
6. Wilson K., Gibson N., Willan A., Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000, 160:939-944.
7. Critchley J.A., Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003, 290:86-97.
8. Ezzati M., Henley S.J., Thun M.J., Lopez A.D. Role of smoking in global and regional cardiovascular mortality. Circulation 2005, 112:489-497.
9. Mohiuddin S.M., Mooss A.N., Hunter C.B., Grollmes T.L., Cloutier D.A., Hilleman D.E. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007, 131:446-452.
10. Rivers J.T., White H.D., Cross D.B., Williams B.F., Norris R.M. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol 1990, 16:340-348.
11. Hasdai D., Garratt K.N., Grill D.E., Lerman A., Holmes DR Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997, 336:755-761.
12. Cho L., Bhatt D.L., Wolski K., Lincoff M., Topol E.J., Moliterno D.J. Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: pooled analysis from EPIC, EPILOG, and EPISTENT. Am Heart J 2001, 141:599-602.
13. Haddock C.K., Poston W.S., Taylor J.E., Conard M., Spertus J. Smoking and health outcomes after percutaneous coronary intervention. Am Heart J 2003, 145:652-657.
14. Weisz G., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T.D., Rutherford B.D., Mehran R., Aymong E., Lansky A., Grines C.L., Stone G.W. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction-the smoker's paradox revisited. Am Heart J 2005, 150:358-364.
15. Taira D.A., Seto T.B., Ho K.K., Krumholz H.M., Cutlip D.E., Berezin R., Kuntz R.E., Cohen D.J. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation 2000, 102:1369-1374.
16. Zhu Z.Y., Gao C.Y., Niu Z.M., Chen Y., Huang K.J., Liu Y.H., Li M.W., Xu Y. Association between smoking status at follow-up and clinical outcomes in patients undergoing successful percutaneous coronary intervention. China J Cardiol 2009, 37:777-780.
17. Fernandez R.S., Griffiths R., Juergens C., Davidson P., Salamonson Y. Persistence of coronary risk factor status in participants 12 to 18 months after percutaneous coronary intervention. J Cardiovasc Nurs 2006, 21:379-387.
18. Meliga E., De Benedictis M., Gagnor A., Belli R., Scrocca I., Lombardi P., Conrotto F., Aranzulla T., Varbella F., Conte M.R. Long-term outcomes of percutaneous coronary interventions with stent implantation in patients <40 years old. Am J Cardiol 2012, 109:1717-1721.
19. Schwietz T., Ehrlich J.R., De Rosa S., Fichtlscherer S., Schachinger V., Baier G., Laskowski R., Zeiher A.M., Spyridopoulos I., Lehmann R. Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: Data from the Frankfurt MV-PCI registry. J Cardiol 2013, 61:38-43.
20. Dai K., Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Miura F., Nakama Y., Otani T., Ooi K., Ikenaga H., Nakamura M., Miki T., Kishimoto S., Sumimoto Y. Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents. J Cardiol 2013, 61:22-30.
21. Okada T., Yoshikawa D., Ishii H., Matsumoto M., Hayakawa S., Matsudaira K., Tanaka M., Kumagai S., Hayashi M., Ando H., Amano T., Murohara T. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris. J Cardiol 2012, 60:264-269.
22. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetière P., Jousilahti P., Keil U., Njølstad I., Oganov R.G., Thomsen T., Tunstall-Pedoe H., Tverdal A., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
23. Jha P., Ramasundarahettige C., Landsman V., Rostron B., Thun M., Anderson R.N., McAfee T., Peto R. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013, 368:341-350.
24. Clair C., Rigotti N.A., Porneala B., Fox C.S., D'Agostino R.B., Pencina M.J., Meigs J.B. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013, 309:1014-1021.